Bacterial Pneumonia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia
Condition: Bacterial Pneumonia Interventions: Drug: Cefiderocol; Drug: Standard of Care Antibiotic Sponsor: Shionogi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
Conditions: Hospital-Acquired Bacterial Pneumonia; Ventilator-Associated Bacterial Pneumonia Interventions: Drug: IMI/REL FDC; Drug: PIP/TAZ FDC; Drug: Linezolid Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2018 Category: Research Source Type: clinical trials